3 More FTSE 100 Shares With Fast-Improving Forecasts: GlaxoSmithKline plc, Smiths Group plc And Schroders plc

GlaxoSmithKline plc (LON:GSK), Smiths Group plc (LON:SMIN) and Schroders plc (LON:SDR) have all received forecast upgrades recently. What is the outlook for the shares?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

GlaxoSmithKline

In the last two months, forecasts for profits at GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have increased from 114p per share to 116p. Combined with the recent share price falls, the stock now looks a combined value-income play.

From the current forecasts, GlaxoSmithKline is on a 2013 price-to-earnings (P/E) ratio of 13.6, falling to 12.3 times the 2014 estimate. Dividends for the year are forecast to hit 77.7p per share, equal to a 4.9% yield at today’s share price. The payout is expected to increase further for 2014, rising to 81.7p — a 5.2% yield.

With the shares down 9% in the last month, Glaxo looks a great opportunity to pick up a blue-chip share with a well-covered high yield.

Schroders

A fund management business will always be a geared play on the health of the financial markets. As equities surged in the period leading up to their May peak, analysts rushed to upgrade Schroders (LSE: SDR). In December, the City was expecting 111.6p of earnings per share (EPS) from Schroders in 2013. By May, this had reached 127.5p.

Despite the recent market setback, I still expect that the next year will see companies like Schroders experience a significant increase in demand.

However, much of that now seems to be in the price. Schroders shares are available today on 16 times 2013 forecasts, with a prospective yield of 2.5%. To justify today’s price, Schroders must meet these expectations. That leaves new buyers exposed to any future deterioration in market conditions.

Smiths Group

On the basic fundamentals, Smiths Group (LSE: SMIN) is the typical FTSE 100 share. The average forward P/E ratio for a UK blue chip is 13. Smiths trades on 13.1 times 2013 forecasts. The average expected yield from a FTSE 100 share is 3.5%. Smiths is expected to pay 3.2%.

The broad range of end markets served by Smiths has protected the business from the worst of the last five years. The oil-and-gas-facing John Crane business made a particularly strong contribution during that period. This helped ensure that the group was able to avoid losses and maintain/increase its shareholder dividend throughout.

A P/E of around 15 might be fairer, given how resilient Smiths Group has proved itself to be.

Buying quality shares at a reasonable price is one of Warren Buffett‘s best-known strategies. Mr Buffett has recently been buying shares in a different FTSE 100 company. To find out which company the world’s best investor has been stocking up on, get our free report “The One UK Share Warren Buffett Loves”. This report is totally free and will be delivered to your inbox immediately. Just click here to start reading today.

> David does not own shares in any of the above companies.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »